Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Top 20 Wellbeing and Wellness Applications for a Sound Way of life - 2Merz: 80% of Syrians in Germany should return in three years
- 31st human missions to Mars should hunt for signs of life, report says
- 4High-Suggested Broilers For Your Homes
- 5She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- France to build new nuclear aircraft carrier, Macron says
- Chevron Says Damage at Wheatstone LNG Will Hamper Restart
- See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- Famous Restroom Beautifying Styles For 2024
- I visited every country by 25. Antarctica showed me how much I still hadn't seen.
- West Bank man indicted for extortion, impersonation of IAF pilot, Mossad agent, illegal entry
- Hezbollah sees potential win as Israel backs down from disarmament goal
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- Is 'Veronica Mars' about to be your new binge-watch? It's now streaming on Netflix.
